VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 56 filers reported holding VERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,541,168 | -19.3% | 914,746 | -5.5% | 0.00% | -50.0% |
| Q2 2023 | $15,537,123 | +4823.3% | 968,045 | +2280.4% | 0.00% | – |
| Q1 2023 | $315,584 | +4.9% | 40,668 | +161.5% | 0.00% | – |
| Q4 2022 | $300,952 | -38.5% | 15,553 | -32.3% | 0.00% | – |
| Q3 2022 | $489,000 | +940.4% | 22,960 | +562.6% | 0.00% | – |
| Q2 2022 | $47,000 | -89.2% | 3,465 | -81.3% | 0.00% | – |
| Q1 2022 | $435,000 | -39.1% | 18,518 | -30.6% | 0.00% | – |
| Q4 2021 | $714,000 | +86.9% | 26,691 | +21.3% | 0.00% | – |
| Q3 2021 | $382,000 | +1491.7% | 22,006 | +1133.5% | 0.00% | – |
| Q2 2021 | $24,000 | – | 1,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |